Every issue, newest first.

A weekly read covering what matters in peptide science — GLP-1s, healing peptides, longevity research, FDA updates. Free to read, free to subscribe.

Launching soon

Issue 001 drops within the next few weeks.

We're finishing the first wave of evidence explainers and wiring up the news desk. Subscribe to get Issue 001 the day it sends, plus a heads-up when the FDA tracker goes live.

One issue per week. No spam. Unsubscribe anytime.